American International Group’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-22,286
Closed -$291K 2476
2024
Q1
$291K Sell
22,286
-191
-0.8% -$2.55K ﹤0.01% 1930
2023
Q4
$287K Sell
22,477
-91
-0.4% -$919 ﹤0.01% 1969
2023
Q3
$296K Buy
22,568
+803
+4% +$14.7K ﹤0.01% 1897
2023
Q2
$557K Buy
21,765
+4,010
+23% +$103K ﹤0.01% 1580
2023
Q1
$447K Buy
17,755
+1,979
+13% +$46.5K ﹤0.01% 1659
2022
Q4
$363K Sell
15,776
-57
-0.4% -$1.31K ﹤0.01% 1778
2022
Q3
$349K Buy
15,833
+223
+1% +$4.31K ﹤0.01% 1803
2022
Q2
$224K Buy
15,610
+676
+5% +$11.4K ﹤0.01% 2115
2022
Q1
$282K Sell
14,934
-1,050
-7% -$20.4K ﹤0.01% 2043
2021
Q4
$298K Buy
15,984
+9,813
+159% +$203K ﹤0.01% 2122
2021
Q3
$166K Buy
6,171
+43
+0.7% +$1.18K ﹤0.01% 2538
2021
Q2
$192 Buy
+6,128
New +$195K ﹤0.01% 2531

Other funds holding TMCI

American International Group's TMCI Position: Q2 2024 in Review

American International Group sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 22,286 shares — an estimated $291K sold.

American International Group first reported a position in TMCI in Q2 2021 and held it in 12 quarters. The position peaked at $557K in Q2 2023. 127 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

  • American International Group reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 22,286 Treace Medical Concepts shares in Q2 2024, an estimated $291K.
  • American International Group first reported a position in Treace Medical Concepts in Q2 2021 and held it in 12 quarters.
  • American International Group's Treace Medical Concepts position peaked at $557K in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.